RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 108 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 4.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $987,000 | +39.2% | 383,963 | +24.6% | 0.00% | 0.0% |
| Q4 2018 | $709,000 | -64.4% | 308,071 | -50.4% | 0.00% | 0.0% |
| Q3 2018 | $1,992,000 | +110.1% | 620,800 | +85.4% | 0.00% | 0.0% |
| Q2 2018 | $948,000 | -18.1% | 334,863 | +2.5% | 0.00% | 0.0% |
| Q1 2018 | $1,157,000 | -10.2% | 326,836 | -1.6% | 0.00% | 0.0% |
| Q4 2017 | $1,288,000 | +66.2% | 332,026 | +8.8% | 0.00% | 0.0% |
| Q3 2017 | $775,000 | -40.0% | 305,136 | -35.5% | 0.00% | 0.0% |
| Q2 2017 | $1,292,000 | -13.3% | 473,151 | +5.0% | 0.00% | 0.0% |
| Q1 2017 | $1,491,000 | +29.4% | 450,545 | -6.9% | 0.00% | 0.0% |
| Q4 2016 | $1,152,000 | -58.4% | 483,839 | -36.0% | 0.00% | -50.0% |
| Q3 2016 | $2,772,000 | +70.6% | 755,430 | +3.7% | 0.00% | +100.0% |
| Q2 2016 | $1,625,000 | -7.1% | 728,544 | -13.4% | 0.00% | 0.0% |
| Q1 2016 | $1,750,000 | -16.5% | 841,512 | +21.7% | 0.00% | -50.0% |
| Q4 2015 | $2,095,000 | +34.6% | 691,355 | +9.7% | 0.00% | +100.0% |
| Q3 2015 | $1,556,000 | -30.1% | 630,055 | -9.2% | 0.00% | -50.0% |
| Q2 2015 | $2,226,000 | +71.2% | 693,555 | +90.4% | 0.00% | +100.0% |
| Q1 2015 | $1,300,000 | +57.2% | 364,253 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $827,000 | +11.2% | 364,253 | -5.0% | 0.00% | 0.0% |
| Q3 2014 | $744,000 | -48.0% | 383,276 | -2.7% | 0.00% | 0.0% |
| Q2 2014 | $1,430,000 | -4.2% | 393,825 | +2.4% | 0.00% | 0.0% |
| Q1 2014 | $1,492,000 | +32.4% | 384,570 | -2.7% | 0.00% | 0.0% |
| Q4 2013 | $1,127,000 | -24.2% | 395,410 | -4.7% | 0.00% | 0.0% |
| Q3 2013 | $1,486,000 | -12.3% | 415,007 | -18.2% | 0.00% | 0.0% |
| Q2 2013 | $1,694,000 | – | 507,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |